2024-03-06 17:49:17 ET
Moderna, Inc. (MRNA)
TD Cowen 44th Annual Health Care Conference
March 06, 2024 01:30 PM ET
Company Participants
Stephen Hoge - President
Conference Call Participants
Tyler Van Buren - TD Cowen
Presentation
Tyler Van Buren
Good afternoon, everyone. Thanks for being here. Welcome again to TD Cowen's 44th Annual Healthcare Conference. My name is Tyler Van Buren, Senior Biotech Analyst here. For this session, it's a privilege to have a fireside chat with Moderna. And from Moderna, it's my pleasure to introduce Stephen Hoge, President. Stephen, thank you very much for being here.
Stephen Hoge
Thanks for having me, Tyler.
Question-and-Answer Session
Q - Tyler Van Buren
If you guys have any questions during the fireside chat, feel free to raise your hand, and I'll do my best to get them asked. We're going to start with COVID. Even though it's becoming naturally -- but even though it's becoming a smaller part of the story, we feel like we have to start there. So to level-set, you guys have mentioned that you'll have $4 billion of vaccine sales guidance for 2024. So it'd be great if you could start just by briefly breaking up those components for us.
Stephen Hoge
Yes, for sure. It is good to be back here with you again. So thanks again for having us. Naturally, we'll talk about COVID. So the $4 billion, there's really three big buckets to it. The first is US sales. I'm sure we'll talk a little bit about vaccination rates in the US because it is a big driver for us as a business. We -- the second is, we have a number of advanced purchase agreements. These are multi-year agreements or even current-year agreements for governments outside the US will purchase for their whole populations or portions of their populations. And then the third and this is a little bit newer from last year is, we will -- we do see some markets where last year we weren't commercializing. Europe is an example, where there has been an issued advanced purchase agreement -- like agreement -- joint purchase agreement from the European Union, and there are opportunities for us to enter into new agreements and then therefore commercialize that....
Read the full article on Seeking Alpha
For further details see:
Moderna, Inc. (MRNA) TD Cowen 44th Annual Health Care Conference (Transcript)